Neuroleptic malignant syndrome with use of quetiapine in mental retardation

Psychiatry and Clinical Neurosciences

Volumn 63, Issue 2, 2009, Pages 255-256

  Dan, Amitava ^a   Bharadwaj, Rahul ^a   Grover, Sandeep ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; LORAZEPAM; QUETIAPINE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DEATH; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; GENERAL CONDITION DETERIORATION; HUMAN; INTELLIGENCE QUOTIENT; INTERSTITIAL PNEUMONIA; LETTER; LUNG CIRCULATION; MALE; MEDICAL EXAMINATION; MENTAL DEFICIENCY; NEUROLEPTIC MALIGNANT SYNDROME; THERAPY EFFECT; TREATMENT RESPONSE;

EID: 62949092983     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2008.01921.x     Document Type: Letter

References (14)

1. Bourgeois JA, Babine S, Meyerovich M, Doyle J. A case of neuroleptic malignant syndrome with quetiapine. J. Neuropsychiatry Clin. Neurosci. 2002 14 : 87.
2. Stanley AK, Hunter J. Possible neuroleptic malignant syndrome with quetiapine. Br. J. Psychiatry 2000 176 : 497.
3. Matsumoto R, Kitabayashi Y, Nakatomi Y, Tsuchida H, Fukui K. Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine. Am. J. Psychiatry 2005 162 : 812.
4. Apikoglu Rabus S, Izzettin F, Rabus M, Bilici M. Severe creatine kinase increase during quetianpine and mirtazapine treatment. Psychopharmacology (Berl.) 2006 185 : 263 264.
5. Bora E, Saffet Gonul A, Akdeniz F, Vahip S. Neuroleptic malignant-like syndrome induced with low-dose quetiapine treated with electroconvulsive therapy. Eur. Psychiatry 2003 18 : 323.
6. Sing KJ, Ramaekers GM, Van Harten PN. Neuroleptic malignant syndrome and quetiapine. Am. J. Psychiatry 2002 159 : 149 150.
7. Al-Waneen R. Neuroleptic malignant syndrome with quetiapine. Can. J. Psychiatry 2000 45 : 764 765.
8. Klein JP, Fiedler U, Appel H, Quante A, Jockers-Scherübl MC. Massive creatine kinase elevations with quetiapine: Report of two cases. Pharmacopsychiatry 2006 39 : 39 40.
9. Whalley N, Diaz P, Howard J. Neuroleptic malignant syndrome associated with the use of quetiapine (letter). Can. J. Hosp. Pharm. 1999 52 : 112.
10. Khan KH, Tham TC. Neuroleptic malignant syndrome induced by quetiapine overdose. Br. J. Hosp. Med. (Lond) 2008 69 : 171.
11. Kobayashi A, Kawanishi C, Matsumura T et al. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: A case report. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006 30 : 1170 1172.
12. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med. Clin. North Am. 1993 77 : 185 202.
13. Hatch CD, Lund BC, Perry PJ. Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics. Pharmacotherapy 2001 21 : 1003 1006.
14. Brieger P, Reinelt Y. No recurrence of a neuroleptic malignant syndrome under quetiapine. Aust. N. Z. J. Psychiatry 2003 37 : 627.